KeyCorp Increases American Healthcare REIT (NYSE:AHR) Price Target to $27.00

American Healthcare REIT (NYSE:AHR) had its target price increased by stock analysts at KeyCorp from $16.00 to $27.00 in a research note issued on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s price target points to a potential upside of 11.16% from the company’s previous close.

AHR has been the subject of several other reports. JMP Securities upped their price objective on American Healthcare REIT from $16.00 to $18.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 7th. Bank of America upped their price objective on American Healthcare REIT from $19.00 to $27.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Morgan Stanley upped their price objective on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, August 22nd. Finally, Truist Financial upped their target price on shares of American Healthcare REIT from $17.00 to $22.00 and gave the stock a “buy” rating in a report on Tuesday, September 3rd. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.38.

American Healthcare REIT Trading Down 0.4 %

NYSE:AHR opened at $24.29 on Monday. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.60. American Healthcare REIT has a 12 month low of $12.63 and a 12 month high of $25.10. The company has a 50 day simple moving average of $18.87 and a two-hundred day simple moving average of $15.84.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.28). The company had revenue of $504.60 million during the quarter, compared to analysts’ expectations of $506.55 million. American Healthcare REIT had a negative return on equity of 2.20% and a negative net margin of 1.99%. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Sell-side analysts expect that American Healthcare REIT will post 1.28 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Kiely Wealth Advisory Group Inc. bought a new position in shares of American Healthcare REIT during the 2nd quarter valued at about $30,000. Amalgamated Bank bought a new position in shares of American Healthcare REIT during the 2nd quarter valued at about $33,000. Commonwealth Equity Services LLC boosted its holdings in shares of American Healthcare REIT by 11.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 23,015 shares of the company’s stock valued at $336,000 after purchasing an additional 2,429 shares during the last quarter. Peak Financial Advisors LLC boosted its holdings in shares of American Healthcare REIT by 10.4% during the 2nd quarter. Peak Financial Advisors LLC now owns 31,126 shares of the company’s stock valued at $455,000 after purchasing an additional 2,921 shares during the last quarter. Finally, Semmax Financial Advisors Inc. bought a new position in shares of American Healthcare REIT in the 2nd quarter valued at about $45,000. Institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.